Evoke Pharma Announces FDA Orange Book Listing of U.S. Patent for Gimoti®
SOLANA BEACH, Calif., June 08, 2021 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on...
Year: 2021
Allena Pharmaceuticals to Host Key Opinion Leader Webinar Focused on ALLN-346 for the Treatment of Gout in Patients with Chronic Kidney Disease
Webinar Scheduled for Wednesday, June 16th @ 12 pm EDTNEWTON, Mass., June 08, 2021 (GLOBE NEWSWIRE) -- Allena Pharmaceuticals (NASDAQ:...
ChemoCentryx Announces Abstract on Avacopan in ANCA-Associated Vasculitis Selected as One of the Ten Best Abstracts at the ERA-EDTA Congress
-- Abstract on ‘The Effect of Avacopan, a Complement C5a Receptor Inhibitor, on Kidney Function in Patients with ANCA-Associated Vasculitis...
MIMEDX Receives Regulatory Approval to Commercialize EPIFIX® in Japan
Availability of EPIFIX Allografts Expected Early 2022 Approval Makes it Possible to Bring EPIFIX’s Healing Properties to as Many as 100,000...
ALR Technologies Announces Formation of an Animal Health Division
Launching the FIRST and ONLY Continuous Glucose Monitor (“CGM”) for Diabetic Companion AnimalsSINGAPORE, June 08, 2021 (GLOBE NEWSWIRE) -- ALR...
Transactions in relation to share buyback program
Pursuant to the authorization granted by the Annual General Meeting of GN Store Nord on March 17, 2021, the Board...
Chinook Therapeutics Presents BION-1301 Interim Phase 1/2 Data in Patients with IgA Nephropathy (IgAN) at the 58th ERA-EDTA Virtual Congress
BION-1301 has been well-tolerated to date in patients with IgAN, with no serious adverse events (SAEs) or treatment discontinuations due...
Patients Living With Diabetes Voice Eagerness for ‘Finger-Prick’ Alternative in Global Glucose Monitoring Survey
Global results show 90% of patients are in favor of a saliva-based glucose testNEW YORK, June 08, 2021 (GLOBE NEWSWIRE)...
Outlook Therapeutics Reports Completion of Patient Dosing in the ONS-5010 Pivotal Phase 3 NORSE TWO Trial
Topline readout of data from NORSE TWO targeted for calendar Q3 2021New Biologics License Application (BLA) filing anticipated in calendar...
Metta World Peace, Former NBA Allstar, Entrepreneur and Mental Health Advocate, Named Chief Impact Director at OOTify, a New Model for Mental Healthcare
Los Angeles , June 08, 2021 (GLOBE NEWSWIRE) -- OOTify, a new mental health hub powered by artificial intelligence (AI),...
Scipher Medicine and Leading Medical Researchers in Network and Data Science Compress Time to Identify COVID-19 Treatments From Years to Months
Study demonstrates Scipher Medicine’s ability to analyze patient data to identify novel treatments.Scipher will focus on pharma collaborations in autoimmune...
IntelGenx’s VetaFilm™ Platform to be Evaluated by One of the World’s Fastest Growing Animal Healthcare Companies
SAINT LAURENT, Quebec, June 08, 2021 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V:IGX) (OTCQB:IGXT) (“IntelGenx”), a leader in pharmaceutical films, today...
Strong Predictive Value of Organoid-Based PARIS® Test to Identify Personalized Treatments in Advanced Cancers Presented at 2021 ASCO Annual Meeting
SEATTLE, June 08, 2021 (GLOBE NEWSWIRE) -- SEngine Precision Medicine, a precision oncology company that pre-tests drugs on patient-derived tumor...
iCAD Signs Global Distribution Agreement with Sectra
Agreement will expand access to ProFound AI and ProFound AI Risk to more facilities and imaging centers worldwideNASHUA, N.H., June...
Celsion Corporation Appoints Dr. Stacy R. Lindborg to its Board of Directors
25-year pharmaceutical industry executive brings broad drug development perspective Replaces Alberto Martinez, MD LAWRENCEVILLE, N.J., June 08, 2021 (GLOBE NEWSWIRE)...
Saniona to Present Preclinical Data on SAN711 at the 7th Congress of the European Academy of Neurology
PRESS RELEASE June 8, 2021 Saniona (OMX: SANION), a clinical stage biopharmaceutical company focused on rare diseases, today announced it...
Pyxis Oncology Strengthens Leadership Team with Executive and Scientific Advisory Board Appointments
– Steve Monks, Ph.D., appointed as Chief Technical Officer, brings 20+ years in drug development and CMC, Quality, and Regulatory...
Immutep Reveals a New Anti-LAG-3 Research Program
SYDNEY, AUSTRALIA, June 08, 2021 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep” or “the Company”), the leading...
BrainsWay to Present at the Raymond James Human Health Innovation Conference
CRESSKILL, N.J. and JERUSALEM, June 08, 2021 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”),...
Ocuphire Announces Appointment of Jay S. Pepose, M.D., Ph.D. to Its Board of Directors
Dr. Pepose is Recognized as an Esteemed Key Opinion Leader in Ophthalmology with Nearly 40 Years of Experience as a...